Wave Life Sciences Stock Fundamentals
| WVE Stock | USD 14.89 0.62 4.34% |
Wave Life Sciences fundamentals help investors to digest information that contributes to Wave Life's financial success or failures. It also enables traders to predict the movement of Wave Stock. The fundamental analysis module provides a way to measure Wave Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Wave Life stock.
At present, Wave Life's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 119 M, whereas Selling General Administrative is forecasted to decline to about 33.7 M. Wave | Select Account or Indicator |
Wave Life Sciences Company Shares Outstanding Analysis
Wave Life's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Wave Life Shares Outstanding | 152.52 M |
Most of Wave Life's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Wave Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Wave Shares Outstanding Historical Pattern
Today, most investors in Wave Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Wave Life's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Wave Life shares outstanding as a starting point in their analysis.
Wave Life Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Wave Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Wave Life Sciences has 152.52 M of shares currently outstending. This is 15.52% lower than that of the Pharmaceuticals sector and 42.74% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 73.33% higher than that of the company.
Wave Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wave Life's current stock value. Our valuation model uses many indicators to compare Wave Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wave Life competition to find correlations between indicators driving Wave Life's intrinsic value. More Info.Wave Life Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Wave Life's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Wave Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Wave Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Wave Life's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Wave Life could also be used in its relative valuation, which is a method of valuing Wave Life by comparing valuation metrics of similar companies.Wave Life is currently under evaluation in shares outstanding category among its peers.
Wave Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of Wave Life from analyzing Wave Life's financial statements. These drivers represent accounts that assess Wave Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Wave Life's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 271.6M | 308.7M | 162.7M | 535.8M | 616.2M | 576.3M | |
| Enterprise Value | 157.0M | 153.5M | 42.1M | 367.6M | 422.7M | 414.9M |
Wave Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Wave Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Wave Life's managers, analysts, and investors.Environmental | Governance | Social |
Wave Fundamentals
| Return On Equity | -2.44 | ||||
| Return On Asset | -0.34 | ||||
| Profit Margin | (2.66) % | ||||
| Operating Margin | 8.33 % | ||||
| Current Valuation | 1.99 B | ||||
| Shares Outstanding | 152.52 M | ||||
| Shares Owned By Insiders | 15.03 % | ||||
| Shares Owned By Institutions | 78.48 % | ||||
| Number Of Shares Shorted | 6.82 M | ||||
| Price To Earning | (6.50) X | ||||
| Price To Book | 16.03 X | ||||
| Price To Sales | 42.36 X | ||||
| Revenue | 113.31 M | ||||
| Gross Profit | (73.64 M) | ||||
| EBITDA | (58.79 M) | ||||
| Net Income | (57.51 M) | ||||
| Cash And Equivalents | 148.16 M | ||||
| Cash Per Share | 1.71 X | ||||
| Total Debt | 32.12 M | ||||
| Debt To Equity | 1.02 % | ||||
| Current Ratio | 2.50 X | ||||
| Book Value Per Share | 0.95 X | ||||
| Cash Flow From Operations | (19.43 M) | ||||
| Short Ratio | 3.38 X | ||||
| Earnings Per Share | (1.12) X | ||||
| Target Price | 22.3 | ||||
| Number Of Employees | 266 | ||||
| Beta | -1.21 | ||||
| Market Capitalization | 2.27 B | ||||
| Total Asset | 274.95 M | ||||
| Retained Earnings | (1.02 B) | ||||
| Working Capital | 48.93 M | ||||
| Current Asset | 161.38 M | ||||
| Current Liabilities | 3.82 M | ||||
| Net Asset | 274.95 M |
About Wave Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Wave Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Wave Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Wave Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 150.1 M | 157.6 M | |
| Total Revenue | 113.3 M | 119 M | |
| Cost Of Revenue | 9.2 M | 8.7 M | |
| Stock Based Compensation To Revenue | 0.09 | 0.08 | |
| Sales General And Administrative To Revenue | 0.45 | 0.43 | |
| Research And Ddevelopement To Revenue | 1.15 | 1.09 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 1.07 | 1.12 | |
| Ebit Per Revenue | (0.60) | (0.63) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:Check out Wave Life Piotroski F Score and Wave Life Altman Z Score analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.427 | Quarterly Revenue Growth (0.11) | Return On Assets (0.34) | Return On Equity (2.44) |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.